Drug Profile
F16 131I
Alternative Names: 131I-F16SIP; F16-131 I; TenaradLatest Information Update: 16 Aug 2022
Price :
$50
*
At a glance
- Originator Philogen
- Class Antineoplastics; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Haematological malignancies; Solid tumours
Most Recent Events
- 16 Aug 2022 Discontinued - Phase-I/II for Haematological malignancies in Italy (Parenteral)
- 16 Aug 2022 Discontinued - Phase-I/II for Solid tumours in Italy (Parenteral)
- 30 Sep 2015 No recent reports of development identified - Phase-I/II for Haematological malignancies in Italy (Parenteral)